Tiedemann Wealth Management LLC raised its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 19.5% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 13,592 shares of the pharmacy operator’s stock after acquiring an additional 2,215 shares during the period. Tiedemann Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $599,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the company. Hudock Capital Group LLC increased its holdings in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 6 shares in the last quarter. Westside Investment Management Inc. increased its holdings in Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 125 shares in the last quarter. IHT Wealth Management LLC increased its holdings in Walgreens Boots Alliance by 46.3% in the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 2,199 shares in the last quarter. Bristlecone Advisors LLC purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth approximately $135,000. Finally, Private Vista LLC increased its holdings in Walgreens Boots Alliance by 6,403.7% in the 2nd quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after acquiring an additional 574,218 shares in the last quarter. Hedge funds and other institutional investors own 61.15% of the company’s stock.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now owns 16,415 shares in the company, valued at $1,105,878.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Stefano Pessina bought 98,858 shares of the business’s stock in a transaction on Monday, January 15th. The stock was bought at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.
WBA has been the subject of a number of research analyst reports. Pivotal Research cut their price objective on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a report on Tuesday, October 24th. Needham & Company LLC reissued a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, October 12th. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 target price for the company. Vetr raised shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Finally, Jefferies Group set a $93.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Sunday, October 29th. Ten analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $86.00.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $79.15 on Monday. The company has a market capitalization of $78,410.00, a price-to-earnings ratio of 21.86, a PEG ratio of 1.32 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating the consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.10 earnings per share. analysts forecast that Walgreens Boots Alliance Inc will post 5.71 EPS for the current year.
Walgreens Boots Alliance announced that its Board of Directors has authorized a share buyback program on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its shares are undervalued.
The company also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be paid a dividend of $0.40 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.02%. Walgreens Boots Alliance’s dividend payout ratio is currently 44.20%.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/01/29/walgreens-boots-alliance-inc-wba-shares-bought-by-tiedemann-wealth-management-llc.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.